To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The study aims to evaluate the efficacy and safety of HRS9531 in subjects with overweight or obese for 48 weeks.
Epistemonikos ID: 5261db4e54df450e7d0530f9b359ed50395236c8
First added on: May 16, 2024